US demand for pharmaceutical packaging will grow 5.5 percent annually through 2012. Strong growth is forecast for value-added types, especially parenteral vials and flip-top closures, plastic dispensing bottles and closures, prefillable inhalers and syringes, parenteral stoppers, track and trace and authentication labels, and unit dose pouches. This study analyzes the $12.2 billion US drug packaging industry. It presents historical demand for the years 1997, 2002 and 2007, and forecasts for 2012 and 2017 by raw and semi-finished material (e.g., plastic, aluminum foil, paper and paperboard, glass); product (e.g., bottles, blister packs, parenteral containers, pouches, inhalers, medication tubes, closures, secondary containers, labels, inserts, wrap, seals, desiccants); and market. The study also considers market environment factors, details industry structure, evaluates company market share and profiles 32 industry players, including MeadWestvaco, Rexam and Alcan Packaging.
Freedonia Market Research—Reports provide industry insights targeting market size, product and market segmentation, product and market forecasts, industry composition, market leaders and business trends.
Any questions about the report you're considering?
Our Customer Service Team can help! Or visit our FAQs.
Search all our
from one place.